AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,989,625 | +56.3% | 882,402 | +26.8% | 0.03% | +50.0% |
| Q1 2023 | $15,988,866 | +214199.2% | 696,076 | +162.0% | 0.02% | +81.8% |
| Q4 2022 | $7,461 | -99.9% | 265,718 | +36.1% | 0.01% | +37.5% |
| Q3 2022 | $5,521,000 | +50.0% | 195,221 | +17.6% | 0.01% | +60.0% |
| Q2 2022 | $3,680,000 | +1.7% | 165,972 | +33.5% | 0.01% | +25.0% |
| Q1 2022 | $3,618,000 | +0.2% | 124,286 | +13.2% | 0.00% | 0.0% |
| Q4 2021 | $3,609,000 | -25.5% | 109,810 | +4.6% | 0.00% | -20.0% |
| Q3 2021 | $4,843,000 | – | 104,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |